PD

A snapshot in time from the 2021 psychedelic bull run

[jungle.java @junglejava1]

YTD $MSOS summary Q1-Q3 Jan 1-Sept 30/22:

30 inflows = 15,240,000 share creates valued at $270,166,850

19 outflows = (4,165,000) share redeems valued at ($78,803,650)

Net increase to S/O = 11,075,000 = net inflows valued at $191,363,200

S/O start 44,815,000 end 55,890,000
8/9

[PSYCSpotlight @PSYC_Spot]

The Narrowing of Psychedelic Discourse

If you lived through the #psychedelic #revolution of the 1960s, you will remember a time when psychedelics represented the pinnacle of human potential as proclaimed by #AldousHuxley & #TimothyLeary

by @jameslkent
https://t.co/yF3jARrnkj

[jungle.java @junglejava1]

MindMed Announces Positive Results from Collaborators' Placebo-Controlled Investigator-Initiated Trial Published in Peer-Reviewed Journal

$MNMD $MMED
https://t.co/GSNdh3YqZV

[PD @PsychDread]

Actually some good info in this article, along with what seems like more good news for the sector, and I appreciated the balanced.

[PSYCSpotlight @PSYC_Spot]

To Hallucinate or Not: The Big Questions Facing #Psychedelics at FENS #2022

The tide around #psychedelic science is changing with the decision by the organizers of @ECNPtweets conference to carve out a slot for #psychedelic research

via @Tech_Networks

https://t.co/DxtwBZzzvr

[PSYCSpotlight @PSYC_Spot]

Yes - You guessed right!

PSYCBiz has changed to PSYC_Spot & is the new home of Psychedelic Spotlight while #Twitter twiddles it's thumbs 😎

$PSYC #TeamPSYC #psychedelics #News #Update #media #lifestyle #culture #psilocybin

[TDR @TheDalesReport]

Another week where the psychedelic industry shows price action resilience among biopharma stocks. @ARKInvest released a much-anticipated and thorough research report that turned heads. And the sector's news flow king, $CYBN, kept it up.

https://t.co/ztZZFJeXZ2

[PD @PsychDread]

It's a shame what this legitimate company posting original content has had to go through.

[PD @PsychDread]

@michaelpollan "If". The last two paragraphs begin with that word. Thank you for sharing. I've come to a point of skepticism myself with these articles where a skeptical stance appears to be an end in itself.

[PSYCSpotlight @PSYC_Spot]

.@CybinInc makes positive progress towards its goal of advancing #psychedelics to #therapeutics

@insidepharma: "Going from the bench to the clinic in 18 months is pretty fantastic"

$CYBN has moved from the lab to the clinic w/ programs underway

https://t.co/EeCs0IereM #stocks

[jungle.java @junglejava1]

The Price history screens have finally updated so I am following up with the inflow details as promised. $PSIL had 275,000 share creates yesterday valued at $1,028,500 so my $1M guess was pretty close! 😁 Have a great day!

[PSYCSpotlight @PSYC_Spot]

As we move deeper into the #Psychedelic Renaissance, many different options are proposed

Psychedelic #decriminalization, medicalization & #legalization are all suggested pathways that each carry their own benefits

So what’s the difference?

https://t.co/MZN79rB6aO
#psychedelics

[PSYCSpotlight @PSYC_Spot]

.@MindsetPharma Further Expands its #IP Portfolio with Three Additional Non-Tryptamine Families of Next-Generation #Psychedelic Compounds

$MSET has purposefully expanded its discovery efforts beyond the #tryptamine drug class into new chemical structures
https://t.co/uM6jSW0u7d

[PD @PsychDread]

@Gr8fulDaytrader I'm happy enough to be down less than 50% at this point! I know that sounds snarky, but my entire psychedelic portfolio has been > 50% down for months. Seeing some stocks getting closer to break even feels good.

[PD @PsychDread]

I was about to share this, then I thought, wait, I'll get @junglejava1 has already shared this. JJ is on it.

"The Company will conduct a conference call and webcast to discuss its results the following morning, Tuesday, August 30, 2022 at 8:30 a.m. ET."

[jungle.java @junglejava1]

Field Trip Health & Wellness Ltd. Reports Fiscal First Quarter 2023 Financial and Operating Results

$FTHW

https://t.co/FGrwLHyW33

[PD @PsychDread]

@Waracken @junglejava1 Etrade. That could be my problem. Also pay $5 for OTC trades.

[PD @PsychDread]

@PSYCBiz, how do you read this in connection with your recent article related to the decision to set aside their 18-MC program? Thanks!

https://t.co/omQfuSGooC

[PSYCSpotlight @PSYC_Spot]

Season Finale of Spotlight in Focus

In this segment @PSYCCEO talks to @TheSporeGroup’s Mia Lowry, @SoundMind_Inst’s Taylor Flatt, @BalancedNetwork’s Ron Millward, & Colette Condorcita of Decriminalize Nature #Philidelphia

https://t.co/OuqEclW1qa

$PSYC #TeamPSYC #psychedelic